Madrigal Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 36 U.S.-traded ETFs. MDGL has around 1.0M shares in the U.S. ETF market. The largest ETF holder of MDGL is the SPDR S&P Biotech ETF (XBI), with approximately 422.08K shares. Investors may also find of interest that the ETF with the largest allocation to MDGL stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 1.40%. On average, U.S. ETFs allocate 0.19% of MDGL to their portfolios.
Additionally, MDGL is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MDGL as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.